Geode Capital Management LLC increased its position in Aadi Bioscience, Inc. (NASDAQ:AADI – Free Report) by 4.1% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 217,294 shares of the company’s stock after buying an additional 8,546 shares during the quarter. Geode Capital Management LLC’s holdings in Aadi Bioscience were worth $686,000 at the end of the most recent reporting period.
Separately, BML Capital Management LLC lifted its holdings in shares of Aadi Bioscience by 5.0% in the 4th quarter. BML Capital Management LLC now owns 2,100,000 shares of the company’s stock valued at $6,626,000 after acquiring an additional 100,000 shares during the last quarter. Institutional investors and hedge funds own 52.08% of the company’s stock.
Aadi Bioscience Trading Up 0.7 %
Shares of AADI opened at $1.48 on Friday. Aadi Bioscience, Inc. has a twelve month low of $1.21 and a twelve month high of $3.81. The company has a market cap of $36.55 million, a P/E ratio of -0.65 and a beta of 0.68. The company’s fifty day simple moving average is $1.86 and its 200-day simple moving average is $2.34.
Aadi Bioscience Company Profile
Aadi Bioscience, Inc, a biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes. Its lead drug product candidate comprises FYARRO, a form of sirolimus protein-bound particles for injectable suspension for the treatment in adult patients with advanced unresectable or metastatic malignant PEComa.
Further Reading
- Five stocks we like better than Aadi Bioscience
- How to Use Stock Screeners to Find Stocks
- The Most Inspiring Small Businesses of 2025 [Survey]
- Conference Calls and Individual Investors
- Microsoft Crushes Earnings, What’s Next for MSFT Stock?
- There Are Different Types of Stock To Invest In
- McDonald’s Insiders Sell Shares! Investors Should Do the Opposite
Want to see what other hedge funds are holding AADI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aadi Bioscience, Inc. (NASDAQ:AADI – Free Report).
Receive News & Ratings for Aadi Bioscience Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aadi Bioscience and related companies with MarketBeat.com's FREE daily email newsletter.